Mary Szela, CEO and President of TriSalus Life Sciences Inc (TLSI, Financial), purchased 14,815 shares of the company on September 13, 2024, according to a recent SEC Filing. This transaction increased the insider's total holdings to 384,677 shares.
TriSalus Life Sciences Inc is focused on transforming the treatment of liver and pancreatic tumors by integrating immunotherapy, drug delivery, and interventional radiology. The company's approach aims to improve patient outcomes by addressing the complexities of these challenging cancers.
The shares were acquired at a price of $5.09 each, placing the total value of the transaction at approximately $75,463.35. Following this purchase, the market cap of TriSalus Life Sciences Inc stands at $132.488 million.
Over the past year, the insider has bought a total of 19,815 shares of TriSalus Life Sciences Inc and has not sold any shares. The company has seen a total of 2 insider buys and 1 insider sell over the same period.
This insider buying activity can be an important indicator for potential investors, as it may reflect the executive's confidence in the company's future performance and alignment with shareholder interests.
For more detailed valuation metrics such as GF Value, price-earnings ratio, price-sales ratio, price-book ratio, and price-to-free cash flow, investors are encouraged to visit the respective links.
This article, generated by GuruFocus, is designed to provide general insights and is not tailored financial advice. Our commentary is rooted in historical data and analyst projections, utilizing an impartial methodology, and is not intended to serve as specific investment guidance. It does not formulate a recommendation to purchase or divest any stock and does not consider individual investment objectives or financial circumstances. Our objective is to deliver long-term, fundamental data-driven analysis. Be aware that our analysis might not incorporate the most recent, price-sensitive company announcements or qualitative information. GuruFocus holds no position in the stocks mentioned herein.
